FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Authors
Keywords
-
Journal
Clinical and Translational Medicine
Volume 11, Issue 2, Pages -
Publisher
Wiley
Online
2021-02-03
DOI
10.1002/ctm2.310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Signaling and RNA Regulation in Cardiovascular Diseases
- (2020) Alessia Mongelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression
- (2020) Wenjing Shang et al. EBioMedicine
- Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology
- (2020) Xiao Yang et al. Molecular Cancer
- m6A-dependent glycolysis enhances colorectal cancer progression
- (2020) Chaoqin Shen et al. Molecular Cancer
- Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity
- (2020) Lijie Wen et al. BMC Urology
- Differential effects on neurodevelopment of FTO variants in obesity and bipolar disorder suggested by in silico prediction of functional impact: An analysis in Mexican population
- (2019) Erasmo Saucedo‐Uribe et al. Brain and Behavior
- Interplay Between N6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer
- (2019) Francesco Fazi et al. Frontiers in Cell and Developmental Biology
- The interplay between m6A RNA methylation and noncoding RNA in cancer
- (2019) Shuai Ma et al. Journal of Hematology & Oncology
- MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma
- (2018) Xuejun Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
- (2018) Nicola Amodio et al. Journal of Hematology & Oncology
- Bladder Cancer: New Insights into Its Molecular Pathology
- (2018) Kentaro Inamura Cancers
- MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines
- (2018) Adheesh Bhandari et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Critical Enzymatic Functions of FTO in Obesity and Cancer
- (2018) Xiaolan Deng et al. Frontiers in Endocrinology
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- FTO expression is associated with the occurrence of gastric cancer and prognosis
- (2017) Dong Xu et al. ONCOLOGY REPORTS
- MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1
- (2017) Haitao Song et al. ONCOLOGY RESEARCH
- Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition
- (2017) Andrew M. Hau et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- FTO is required for myogenesis by positively regulating mTOR-PGC-1α pathway-mediated mitochondria biogenesis
- (2017) Xiaobo Wang et al. Cell Death & Disease
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
- (2017) Haibiao Xie et al. Journal of Cancer
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis
- (2017) Jingwen Li et al. PLoS One
- Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
- (2016) Masayoshi Nagata et al. DISEASE MARKERS
- N6-methyladenosine Modulates Messenger RNA Translation Efficiency
- (2015) Xiao Wang et al. CELL
- FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
- (2014) Xu Zhao et al. CELL RESEARCH
- MAL2 expression predicts distant metastasis and short survival in pancreatic cancer
- (2013) Daiki Eguchi et al. SURGERY
- FTO levels affect RNA modification and the transcriptome
- (2012) Tea Berulava et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2
- (2012) Shudao Xiong et al. International Journal of Biological Sciences
- Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls
- (2012) Guiqiong Li et al. TUMOR BIOLOGY
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
- (2010) Jennifer A Byrne et al. BMC CANCER
- The genetics of obesity: FTO leads the way
- (2010) Katherine A. Fawcett et al. TRENDS IN GENETICS
- Metabolomics in biomarker discovery: future uses for cancer prevention
- (2008) Young S Kim et al. Future Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now